Pereţianu D, Grigorie D, Popescu F, Zaharescu J
Department of Endocrinology and Applied Immunology, St. John Hospital, Bucharest, Romania.
Endocrinologie. 1990 Jul-Dec;28(3-4):199-205.
The present study investigates if bone scintigraphy could be used as a diagnostic and prognostic tool in acromegaly. Bone scintigraphy (99m Tc-diphosphonate) was performed in 10 acromegalic (7 active and 3 inactive acromegaly) vs 12 control patients. Isotope uptake (in counts/cell) was assessed in the area of interest 3-4 hours after diphosphonate administration. Three views were chosen: cranium lateral (I)/frontal (II), and the hands (III). Between the acromegalic and control patients there were significant differences (x = p less than 0.001; xx = p less than 0.05) for the following areas: I-parietal: 66.5 vs 24.82x; I-occipital: 58.4 vs 23x; I-mediosphenoidal temporal: 55.2 vs 21.36x: I-nasal: 55.9 vs 38.73 xx; II-frontal: 46.8 vs 16.64 x; II-nasal: 59.8 vs 40.27 xx; III-left metacarpal: 21.67 vs 15.36 xx; III-right metacarpal: 21.78 vs 16.18 xx. Surprisingly, bone isotope uptake at the mandibular level, both in lateral and frontal view, showed no significant differences between acromegalic and control patients (55.2 vs 45 and 59.8 vs 44.5). Between the active and nonactive acromegalic patients there were no significant differences in any area. Bone scintigraphy, therefore, does not represent a useful index for disease activity. However, the results gave rise to two interesting problems: the acromegalic bone seems to have the same metabolic activity irrespective of the disease status; why is bone isotope uptake the same in acromegalics with pronounced prognathism as in the controls with normal mandible?
本研究调查骨闪烁扫描术是否可作为肢端肥大症的诊断和预后工具。对10例肢端肥大症患者(7例活动期和3例非活动期肢端肥大症)和12例对照患者进行了骨闪烁扫描术(99m锝二膦酸盐)。在给予二膦酸盐后3 - 4小时,在感兴趣区域评估同位素摄取(计数/细胞)。选择了三个视图:颅骨侧位(I)/正位(II)以及手部(III)。在肢端肥大症患者和对照患者之间,以下区域存在显著差异(x = p小于0.001;xx = p小于0.05):I - 顶骨:66.5对24.82x;I - 枕骨:58.4对23x;I - 蝶骨中部颞部:55.2对21.36x;I - 鼻骨:55.9对38.73 xx;II - 额骨:46.8对16.64 x;II - 鼻骨:59.8对40.27 xx;III - 左手掌骨:21.67对15.36 xx;III - 右手掌骨:21.78对16.18 xx。令人惊讶的是,在侧位和正位视图中,肢端肥大症患者和对照患者在下颌骨水平的骨同位素摄取均无显著差异(55.2对45以及59.8对44.5)。在活动期和非活动期肢端肥大症患者之间,任何区域均无显著差异。因此,骨闪烁扫描术并非疾病活动的有用指标。然而,这些结果引发了两个有趣的问题:无论疾病状态如何,肢端肥大症患者的骨骼似乎具有相同的代谢活性;为什么下颌前突明显的肢端肥大症患者的骨同位素摄取与下颌正常的对照患者相同?